REZZA, GIOVANNI
 Distribuzione geografica
Continente #
AS - Asia 6.592
EU - Europa 5.397
NA - Nord America 4.082
SA - Sud America 1.036
AF - Africa 155
OC - Oceania 15
Continente sconosciuto - Info sul continente non disponibili 1
Totale 17.278
Nazione #
US - Stati Uniti d'America 3.868
RU - Federazione Russa 3.668
SG - Singapore 2.861
CN - Cina 1.791
BR - Brasile 877
HK - Hong Kong 862
IT - Italia 490
VN - Vietnam 469
FR - Francia 343
DE - Germania 234
GB - Regno Unito 181
BD - Bangladesh 129
CA - Canada 102
AT - Austria 90
IN - India 85
FI - Finlandia 77
NL - Olanda 69
MX - Messico 63
AR - Argentina 59
SE - Svezia 59
PL - Polonia 55
TR - Turchia 52
IQ - Iraq 48
ZA - Sudafrica 45
JP - Giappone 39
PK - Pakistan 38
ES - Italia 32
ID - Indonesia 29
SA - Arabia Saudita 26
EC - Ecuador 25
AE - Emirati Arabi Uniti 22
CO - Colombia 19
CZ - Repubblica Ceca 19
LT - Lituania 17
MY - Malesia 17
JM - Giamaica 16
PH - Filippine 16
KE - Kenya 15
PY - Paraguay 15
AU - Australia 14
MA - Marocco 14
UZ - Uzbekistan 14
VE - Venezuela 14
DZ - Algeria 13
NG - Nigeria 13
UA - Ucraina 13
EG - Egitto 12
CL - Cile 11
JO - Giordania 11
TW - Taiwan 11
CR - Costa Rica 10
NP - Nepal 10
TN - Tunisia 10
BE - Belgio 9
IL - Israele 8
KR - Corea 8
CH - Svizzera 7
BO - Bolivia 6
IE - Irlanda 6
KG - Kirghizistan 6
TH - Thailandia 6
UY - Uruguay 6
AZ - Azerbaigian 5
GR - Grecia 5
IR - Iran 5
KZ - Kazakistan 5
GH - Ghana 4
HR - Croazia 4
SN - Senegal 4
UG - Uganda 4
AL - Albania 3
CM - Camerun 3
CU - Cuba 3
ET - Etiopia 3
HU - Ungheria 3
KH - Cambogia 3
LB - Libano 3
OM - Oman 3
PE - Perù 3
RO - Romania 3
RS - Serbia 3
AO - Angola 2
BB - Barbados 2
BG - Bulgaria 2
BZ - Belize 2
CI - Costa d'Avorio 2
DO - Repubblica Dominicana 2
GT - Guatemala 2
HN - Honduras 2
LA - Repubblica Popolare Democratica del Laos 2
LY - Libia 2
NI - Nicaragua 2
PA - Panama 2
PS - Palestinian Territory 2
SV - El Salvador 2
TT - Trinidad e Tobago 2
AF - Afghanistan, Repubblica islamica di 1
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
BN - Brunei Darussalam 1
Totale 17.257
Città #
Singapore 1.401
San Jose 1.125
Hong Kong 849
Moscow 807
Ashburn 679
Dallas 577
Shanghai 406
Hefei 331
Lauterbourg 287
Ho Chi Minh City 184
Beijing 145
Hanoi 113
New York 111
Los Angeles 98
São Paulo 86
Santa Clara 73
Nuremberg 69
Milan 58
Brooklyn 57
Munich 51
Rome 51
Warsaw 49
Boardman 47
Orem 47
Lappeenranta 41
Council Bluffs 40
Vienna 40
Tokyo 34
Denver 33
Montreal 33
Atlanta 32
Stockholm 31
Kassel 30
Rio de Janeiro 30
Chicago 29
London 27
Assago 26
Guangzhou 26
Chennai 25
Johannesburg 25
Mexico City 25
Amsterdam 24
Ankara 23
Boston 22
Da Nang 22
Phoenix 21
Turku 21
Hangzhou 19
Poplar 19
Toronto 18
Baghdad 17
Belo Horizonte 17
Buffalo 17
Curitiba 17
Haiphong 16
Lahore 16
Seattle 16
Wolfhagen 16
Brno 15
Frankfurt am Main 15
Manchester 15
Romagnano Sesia 15
Mumbai 13
San Francisco 13
Goiânia 12
Helsinki 12
Jeddah 12
Nairobi 12
Amman 11
Cesano Boscone 11
City of London 11
Guayaquil 11
Kingston 11
Porto Alegre 11
Shenzhen 11
Tashkent 11
Changsha 10
Kuala Lumpur 10
Salvador 10
Buenos Aires 9
Cairo 9
Cape Town 9
Casoria 9
Charlotte 9
Erbil 9
Houston 9
Princeton 9
Riyadh 9
Washington 9
Xi'an 9
Abu Dhabi 8
Athens 8
Brasília 8
Lawrence 8
San José 8
Sydney 8
São Bernardo do Campo 8
Tianjin 8
Birmingham 7
Biên Hòa 7
Totale 8.978
Nome #
Climate change, human migration and health nexus: what do we know about public health implications on a global scale? 165
Effectiveness of mRNA vaccines and waning of protection against SARS-CoV-2 infection and severe covid-19 during predominant circulation of the delta variant in Italy: Retrospective cohort study 142
The new Italian National Immunization Technical Advisory Group (NITAG) and its commitment to endorse a new efficient National Immunization Plan in COVID-19 times 134
AIDS and injecting drug use: survival determinants in the highly active antiretroviral therapy era 121
2) HERV-H per l'uso come marcatore molecolare del Disturbo dello Spettro Autistico e relativo metodo diagnostico in vitro, kit diagnostico e usi medici (2012).GAUDI S F 116
Protection against severe COVID-19 after second booster dose of adapted bivalent (original/Omicron BA.4-5) mRNA vaccine in persons ≥ 60 years, by time since infection, Italy, 12 September to 11 December 2022 110
L'accesso alle cure della persona straniera: indicazioni operative 108
COVID-19 vaccines: where we stand and challenges ahead 107
Aedes albopictus and the reemergence of Dengue 107
Relative effectiveness of monovalent and bivalent mRNA boosters in preventing severe COVID-19 due to omicron BA.5 infection up to 4 months post-administration in people aged 60 years or older in Italy: a retrospective matched cohort study 106
Vaccinating in Different Settings: Best Practices from Italian Regions 106
Adult vaccination as the cornerstone of successful ageing: the case of herpes zoster vaccination. A European Interdisciplinary Council on Ageing (EICA) expert focus group 101
Estimated Effectiveness of a Primary Cycle of Protein Recombinant Vaccine NVX-CoV2373 Against COVID-19 101
A Caprine Herpesvirus 1 Vaccine Adjuvanted with MF59 (TM) Protects against Vaginal Infection and Interferes with the Establishment of Latency in Goats 100
Relative effectiveness of a 2nd booster dose of COVID-19 mRNA vaccine up to four months post administration in individuals aged 80 years or more in Italy: A retrospective matched cohort study 100
Tracking the progressive spread of the SARS-CoV-2 Omicron variant in Italy, December 2021 to January 2022 99
A SARS-CoV-2 Outbreak Among Nursing Home Residents Vaccinated with a Booster Dose of mRNA COVID-19 Vaccine 99
A community-acquired Legionnaires' disease outbreak caused by Legionella pneumophila serogroup 2: An uncommon event, Italy, August to October 2018 98
Acute respiratory distress syndrome due to influenza virus A/H1N1v in a patient with HIV/HCV co-infection 94
A vaccine against Ebola: Problems and opportunities 93
An outbreak of Q fever in Bulgaria 92
Vaccine coverage and determinants of incomplete vaccination in children aged 12-23 months in Dschang, West Region, Cameroon: a cross-sectional survey during a polio outbreak 91
Monitoring medicine prescriptions before, during and after pregnancy in Italy 90
Effectiveness of an mRNA vaccine booster dose against SARS-CoV-2 infection and severe COVID-19 in persons aged ≥60 years and other high-risk groups during predominant circulation of the delta variant in Italy, 19 July to 12 December 2021 90
La storia dell' infezione da HIV in Italia: epidemiologia ,trend e problemi del sommerso 90
Relative effectiveness of bivalent Original/Omicron BA.4-5 mRNA vaccine in preventing severe COVID-19 in persons 60 years and above during SARS-CoV-2 Omicron XBB.1.5 and other XBB sublineages circulation, Italy, April to June 2023 89
A desk review on institutional and non-institutional organizations active in the field of migrant's health in the WHO European Region 89
Analysis of Genomic Characteristics of SARS-CoV-2 in Italy, 29 January to 27 March 2020 88
The impact of DAA-mediated HCV eradication on CD4+ and CD8+ T lymphocyte trajectories in HIV/HCV coinfected patients: Data from the ICONA Foundation Cohort 88
Diagnosis of Imported Dengue and Zika Virus Infections in Italy from November 2015 to November 2022: Laboratory Surveillance Data from a National Reference Laboratory 87
Effectiveness of BNT162b2 vaccine against SARS-CoV-2 infection and severe COVID-19 in children aged 5–11 years in Italy: a retrospective analysis of January–April, 2022 87
SARS-CoV-2 transmission in the lombardy region: The increase of household contagion and its implication for containment measures 87
A large food-borne outbreak of campylobacteriosis in kindergartens and primary schools in Pescara, Italy, May–June 2018 87
A large ongoing outbreak of hepatitis A predominantly affecting young males in Lazio, Italy; August 2016 - March 2017 85
An outbreak of severe invasive meningococcal disease due to a capsular switched Neisseria meningitidis hypervirulent strain B:cc11 85
The law on compulsory vaccination in italy: An update 2 years after the introduction 82
Attitudes and practices of dentists treating patients infected with human immunodeficiency virus in the era of highly active antiretroviral therapy 82
An atypical case of multifocal infantile haemangioma in a child after Highly Active Antiretroviral Therapy (HAART) during pregnancy 81
An autochthonous case of Zika due to possible sexual transmission, Florence, Italy, 2014 81
Estimating SARS-CoV-2 infections and associated changes in COVID-19 severity and fatality 81
Evaluation of HIV transmission clusters among natives and foreigners living in Italy 81
Psychiatric disorders among hospitalized patients deceased with COVID-19 in Italy 79
An early start of west nile virus seasonal transmission: The added value of one heath surveillance in detecting early circulation and triggering timely response in Italy, June to July 2018 79
Co-circulation of SARS-CoV-2 Alpha and Gamma variants in Italy, February and March 2021 79
Childhood Immunisation Coverage during the COVID-19 Epidemic in Italy 76
Evaluating the effect of targeted strategies as control tools for hypervirulent meningococcal C outbreaks: a case study from Tuscany, Italy, 2015 to 2016 75
Acute Flaccid Paralysis surveillance in Bosnia and Herzegovina: recent isolation of two Sabin like type 2 poliovirus 74
Chikungunya fever in Africa: a systematic review 74
AIDS, Drug Misuse and the Global Crisis. In: AIDS and Drug Misuse: the challenge for policy and practice in 1990s. 72
Clinical characteristics of individuals with Down syndrome deceased with CoVID-19 in Italy—A case series 71
O’nyong-nyong fever: a neglected mosquito-borne viral disease 71
Vaccination of 50+ adults to promote healthy ageing in Europe: The way forward 70
COVID-19 Vaccines: Current and Future Perspectives 70
Temporal variations in excess mortality during phase 1 and phase 2 of the covid-19 epidemic in italy 70
Rapid increase in neuroinvasive West Nile virus infections in humans, Italy, July 2022 69
Bayesian Phylogeography of Crimean-Congo Hemorrhagic Fever Virus in Europe 69
Are vaccine shortages a relevant public health issue in Europe? Results from a survey conducted in the framework of the EU Joint Action on Vaccination 69
Vaccinations in migrants and refugees: a challenge for European health systems. A systematic review of current scientific evidence. 68
Increasing Number of Cases Due to Candida auris in North Italy, July 2019–December 2022 67
Do we need a vaccine against chikungunya? 66
Vaccine preventable invasive bacterial diseases in Italy: A comparison between the national surveillance system and recorded hospitalizations, 2007–2016 66
Effectiveness of Vaccination against SARS-CoV-2 Infection in the Pre-Delta Era: A Systematic Review and Meta-Analysis 66
The common European mosquitoes Culex pipiens and Aedes albopictus are unable to transmit SARS-CoV-2 after a natural-mimicking challenge with infected blood 65
The impact of SARS-CoV-2 infection in patients with cystic fibrosis undergoing CFTR channel modulators treatment: a literature review 65
LASSO Regression Modeling on Prediction of Medical Terms among Seafarers’ Health Documents Using Tidy Text Mining 65
Prevalence of SARS-CoV-2 infection in Italian pediatric population: a regional seroepidemiological study 65
Gene flow and Bayesian phylogeography of serogroup C meningococci circulating in Italy 65
Case-Fatality Rate and Characteristics of Patients Dying in Relation to COVID-19 in Italy 65
Whole genome and phylogenetic analysis of two SARSCoV-2 strains isolated in Italy in January and February 2020: Additional clues on multiple introductions and further circulation in Europe 65
Continuous increase in HIV-1 incidence after the year 2000 among men who have sex with men in Rome: insights from a 25-year retrospective cohort study 64
Sex differences in clinical phenotype and transitions of care among individuals dying of COVID-19 in Italy 64
Evolution of Pathology Patterns in Persons Who Died From COVID-19 in Italy: A National Study Based on Death Certificates 63
Evolution of SARS-CoV-2 IgG Seroprevalence in Children and Factors Associated with Seroconversion: Results from a Multiple Time-Points Study in Friuli-Venezia Giulia Region, Italy 63
Estimates of the reproductive numbers and demographic reconstruction of outbreak associated with C:P1.5 – 1,10 – 8:F3 – 6:ST – 11(cc11) Neisseria meningitidis strains 63
Health and Climate Change: Science calls for global action 62
Durability of neutralizing antibodies against yellow fever virus after vaccination in healthy adults 62
VIRAL HEPATITIS, HIV, HUMAN HERPES VIRUS AND TREPONEMA PALLIDUM INFECTION IN HAEMODIALYSIS PATIENTS FROM KOSOVO, 2005 62
Tick-borne encephalitis in north-east Italy: a 14-year retrospective study, January 2000 to December 2013 62
Primary prevention of congenital anomalies: Special focus on environmental chemicals and other toxicants, maternal health and health services and infectious diseases 61
Phylogeography and epidemiological history of West Nile virus genotype 1a in Europe and the Mediterranean basin 61
Human mpox: global trends, molecular epidemiology and options for vaccination 61
Long Covid: where we stand and challenges ahead 61
Reactive vaccination as control strategy for an outbreak of invasive meningococcal disease caused by Neisseria meningitidis C:P1.5-1,10-8:F3-6:ST-11(cc11), Bergamo province, Italy, December 2019 to January 2020 61
Survival After AIDS Diagnosis in Italy, 1999-2006: A Population-Based Study 61
From mass vaccination to personalized vaccinology? The COVID-19 case. Commentary 60
Epidemiological characteristics of COVID-19 cases and estimates of the reproductive numbers 1 month into the epidemic, Italy, 28 January to 31 March 2020 60
The effect of COVID-19 vaccination in Italy and perspectives for living with the virus 60
Variable Impact on Mortality of AIDS-Defining Events Diagnosed during Combination Antiretroviral Therapy: Not All AIDS-Defining Conditions Are Created Equal 60
Virological response and retention in care according to time of starting ART in Italy: Data from the Icona Foundation Study cohort 60
Imported and indigenous cases of invasive meningocococcal disease W:P1.5,2:F1-1: ST-11 in migrants’ reception centers. Italy, June-November 2014 59
Immunologic Response to Highly Active Antiretroviral Therapy and Mortality Reduction in a Cohort of Human Immunodeficiency Virus-Positive Persons in Mozambique 59
Risk behaviour and HTLV-1 seropositivity in injecting drug users 59
HPV Vaccination during the COVID-19 Pandemic in Italy: Opportunity Loss or Incremental Cost 58
Omicron variant evolution on vaccines and monoclonal antibodies 58
Impact of a nationwide lockdown on SARS-CoV-2 transmissibility, Italy 58
Targeting Candidates for Directly Administered Highly Active Antiretroviral Therapy: Benefits Observed in HIV-Infected Injecting Drug Users in Residential Drug-Rehabilitation Facilities 57
Transmission of HIV drug resistance and the predicted effect on current first-line regimens in Europe 57
Childhood Immunization Coverage Before, During and After the COVID-19 Pandemic in Italy 57
The Magnitude of Cardiovascular Disease Risk Factors in Seafarers from 1994 to 2021: A Systematic Review and Meta-Analysis 57
Multiplex real-time reverse-transcription polymerase chain reaction assays for diagnostic testing of severe acute respiratory syndrome coronavirus 2 and seasonal influenza viruses: A challenge of the phase 3 pandemic setting 57
Totale 7.842
Categoria #
all - tutte 90.339
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 90.339


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20226 0 0 0 1 0 0 3 2 0 0 0 0
2022/202346 17 11 2 0 2 5 4 4 1 0 0 0
2023/2024896 0 0 9 8 3 3 0 212 361 35 52 213
2024/20254.159 550 96 43 124 133 350 463 335 721 701 323 320
2025/202612.756 977 1.067 611 1.361 914 389 1.989 819 3.263 696 384 286
Totale 17.867